ArticleMedical oncology (Northwood, London, England)2018

Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.

Sakae Konishi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.